Savas Tay to Antiviral Agents
This is a "connection" page, showing publications Savas Tay has written about Antiviral Agents.
Connection Strength
1.203
-
HSV-1 single-cell analysis reveals the activation of anti-viral and developmental programs in distinct sub-populations. Elife. 2019 05 15; 8.
Score: 0.516
-
A drug repurposing screen identifies decitabine as an HSV-1 antiviral. Microbiol Spectr. 2024 Nov 05; 12(11):e0175424.
Score: 0.187
-
Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses. Sci Adv. 2022 Feb 25; 8(8):eabi6110.
Score: 0.157
-
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2. Science. 2021 08 20; 373(6557):931-936.
Score: 0.150
-
Discovery of SARS-CoV-2 main protease inhibitors using a synthesis-directed de novo design model. Chem Commun (Camb). 2021 Jun 15; 57(48):5909-5912.
Score: 0.149
-
Development of Masitinib Derivatives with Enhanced Mpro Ligand Efficiency and Reduced Cytotoxicity. Molecules. 2023 Sep 15; 28(18).
Score: 0.044